# reload+after+2024-01-20 02:39:59.812554
address1§Innovation Centre
address2§Innovation Way Heslington
city§York
zip§YO10 5DG
country§United Kingdom
website§https://www.optibiotix.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulators primarily in the United Kingdom. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that impacts human physiology deriving potential health benefits. Its products include Slimbiome, a natural ingredient, which offers a healthy and hunger-free weight management system; SlimBiome Medical, a natural supplement for weight management; CholBiome, a food supplement for maintaining healthy levels of cholesterol; Lactobacillus plantarum LPLDL, a probiotic that aids elements of cardiovascular and wellbeing; LPGOS, a galactooligosaccharid that is used in food products and applications, which helps in reducing cardiovascular risk factors and enhancing health; and Sweetbiotix, a sweetener for use in food and beverages. The company's products prevents and manages chronic lifestyle diseases, including obesity, hypercholesterolemia, and diabetes. OptiBiotix Health Plc was incorporated in 2006 and is headquartered in York, the United Kingdom.
fullTimeEmployees§9
companyOfficers§[{'maxAge': 1, 'name': "Mr. Stephen Patrick O'Hara", 'age': 63, 'title': 'Founder, CEO & Executive Director', 'yearBorn': 1960, 'fiscalYear': 2022, 'totalPay': 151000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Sofia  Kolyda', 'age': 50, 'title': 'Executive Director of Research & Development and Executive Director', 'yearBorn': 1973, 'fiscalYear': 2022, 'totalPay': 88000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Mark Kingsley Collingbourne', 'age': 57, 'title': 'CFO & Secretary', 'yearBorn': 1966, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Paul  Cannings', 'title': 'Head of Operations & Quality', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Kevin James Newman', 'title': 'Corporate Development Director', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Karl  Burkitt', 'title': 'Marketing Director', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§1.56
priceToSalesTrailing12Months§35.404194
currency§GBp
exchange§LSE
quoteType§EQUITY
shortName§OPTIBIOTIX HEALTH PLC ORD 2P
longName§OptiBiotix Health Plc
firstTradeDateEpochUtc§1315551600
timeZoneFullName§Europe/London
timeZoneShortName§GMT
uuid§3992c20e-e7a9-313f-85ee-b3875bb197d5
recommendationMean§3.0
recommendationKey§hold
quickRatio§3.239
grossMargins§0.49347
ebitdaMargins§-2.91001
trailingPegRatio§None
